Henry: Methods for Initiating Insulin Therapy
Diabetology
Credits:
1 AMA PRA Category 1 Credit(s) ™
1 AMA PRA Category 1 Credit(s) ™
Launch Date:
December 24, 2014
December 24, 2014
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Primary Care Clinicians (e.g., MD, DO, NP, PA) who provide primary or front-line care for people with diabetes; including family practice physicians and internists; Specialists (e.g., cardiologists, nephrologists) who serve a significant role in the care of patients and who might have responsibility for insulin management; and office staff of any of these physician categories
Relevant Terms:
Type 2 diabetes; Insulin Therapy; Primary Care
Greeshma K Shetty, MD
Greeshma K Shetty, MD
Instructor of Medicine
Endocrinology, Metabolism & Diabetes
Harvard Medical School
Joslin Diabetes Center
Beth Israel Deaconess Medical Center
Boston, MA
Bio
Dr. Greeshma K. Shetty is an Instructor in Medicine at Harvard Medical School, teaching diabetes and general endocrinology (which includes diabetes, thyroid disease, parathyroid disease, adrenal disease, lipid management, hypertension, pituitary disease, and bone metabolism) to students, residents, and fellows. She is also a practicing endocrinologist on the clinical staff at both Joslin Diabetes Center and Beth Israel Deaconess Medical Center (BIDMC) in Boston.
Dr. Shetty attended Albany Medical College in New York and completed her internship, residency, and fellowship in endocrinology at BIDMC before joining the clinical staff. She earned several awards and recognitions for outstanding achievement during her undergraduate and medical school years, culminating in Harvard Medical School recognizing her superb teaching ability by conferring its Resident Teaching Award during her residency.
| 1. | Identify people for whom insulin therapy initiation or advancement is indicated as reflected by A1C and glycemic patterns | 2. | Design insulin treatment programs based on A1C, glycemic patterns, and an individualized assessment of underlying pathophysiology, comorbidities, self-care abilities, and patient perspectives |
| 3. | Describe what is needed, and self-assess one's own practice for current and potential care and support services, to optimize insulin initiation, titration, and patient support |
| 1. | Identify people for whom insulin therapy initiation or advancement is indicated as reflected by A1C and glycemic patterns |
| 2. | Design insulin treatment programs based on A1C, glycemic patterns, and an individualized assessment of underlying pathophysiology, comorbidities, self-care abilities, and patient perspectives |
| 3. | Describe what is needed, and self-assess one's own practice for current and potential care and support services, to optimize insulin initiation, titration, and patient support |
Core Competencies:
| ACGME CORE COMPETENCIES |
| X Patient Care |
| X Medical Knowledge |
| X Practice-Based Learning and Improvement |
| Interpersonal Skills and Communication |
| Professionalism |
| Systems Based Practice |
Faculty
Course Director: Dr. Richard Beaser
Richard S. Beaser, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Medical Executive Director, Professional Education
Joslin Diabetes Center
Boston, MA
Richard Beaser, MD, is the Medical Executive Director of Professional Education, Joslin Diabetes Center. He is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has been on the staff of Joslin Diabetes Center since 1982. He has held numerous positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has written 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin's Diabetes Deskbook: A Guide for Primary Care Providers. Dr. Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous articles in peer-reviewed journals, review articles, and book chapters. In 1990, Dr. Beaser co-founded Joslin's Professional Education Department, which was incorporated into the Joslin Strategic Initiatives Division in 2000. As Medical Executive Director of this department, Dr. Beaser has overall responsibility for departmental activities. He specifically focuses on development or oversight of all the department's educational content for physicians, other medical professionals, and patients. He is responsible for the business and project development aspects of the department as well, working collaboratively to conceive, develop, and seek funding for all departmental projects and activities.
Greeshma K. Shetty, MD
Instructor of Medicine
Endocrinology, Metabolism & Diabetes
Harvard Medical School
Staff Physician
Joslin Diabetes Center
Beth Israel Deaconess Medical Center
Boston, MA
Dr. Greeshma K. Shetty is an Instructor in Medicine at Harvard Medical School, teaching diabetes and general endocrinology (which includes diabetes, thyroid disease, parathyroid disease, adrenal disease, lipid management, hypertension, pituitary disease, and bone metabolism) to students, residents, and fellows. She is also a practicing endocrinologist on the clinical staff at both Joslin Diabetes Center and Beth Israel Deaconess Medical Center (BIDMC) in Boston.
Dr. Shetty attended Albany Medical College in New York and completed her internship, residency, and fellowship in endocrinology at BIDMC before joining the clinical staff. She earned several awards and recognitions for outstanding achievement during her undergraduate and medical school years, culminating in Harvard Medical School recognizing her superb teaching ability by conferring its Resident Teaching Award during her residency.
Dr. Shetty is board-certified in both Internal Medicine and Endocrinology. In addition to teaching, she maintains an endocrinology practice at BIDMC and Joslin Diabetes Center in Boston, where she cares for patients on both inpatient and outpatient services. She also conducts research, currently serving as co-principal investigator on two research projects delving into the effect of dietary fat and glycemic index on glycemic control, and into cognitive function during hypoglycemia and recovery.
DISCLOSURE POLICY STATEMENT
As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning and/or CME advisory committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning and CME advisory committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services, with the exception of nonprofit or government organizations and non–healthcare-related companies, which are exempt.
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.
If a faculty or planning committee member has no information to disclose, this information will also be provided. If a faculty or planning committee member refuses to disclose, he/she will not be able to participate in the planning, management, presentation, or evaluation of any Joslin Diabetes Center CME activity. In addition, faculty have been asked to disclose when a product or device is not labeled for the use under discussion. The opinions and comments expressed in this program are those of the speakers and should not be considered the opinions or comments of Joslin Diabetes Center.
Faculty Disclosures
- Dr. Richard S. Beaser,* Senior Staff Physician, Joslin Diabetes Center, is on the academic advisory panel for Boehringer Ingelheim Pharmaceuticals, Inc.
- Dr. Lyle Mitzner has no relevant financial relationships.
- Dr. Mark E. Molitch is a consultant for Lilly USA, LLC; Merck & Co., Inc.; Pfizer Inc.; and Janssen Pharmaceuticals, Inc.; and is a consultant and receives grant/research support from Novartis Pharmaceuticals Corporation and Novo Nordisk Inc.
- Dr. Greeshma K. Shetty has no relevant financial relationships.
Copyright © 2014 by Joslin Diabetes Center, Inc. All rights reserved.
CREDIT DESIGNATION
Joslin Diabetes Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™ per virtual clinic. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACCREDITATION STATEMENT
Joslin Diabetes Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with ACCME Essentials. Health professionals not eligible for continuing medical education credit will receive a certificate of participation that they may submit to their state licensing board for credit.
HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1 AMA PRA Category 1 Credits™ per activity. Statement of credit will be available to print from your user history page.
- Read the learning objectives and faculty disclosures.
- Participate in the activity.
- Complete the post-test and activity evaluation.
- Physicians who successfully complete the post-test and evaluation will receive CME credit. You must score with a 70% or higher on the post-test to receive credit for this activity.
- All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
This activity is supported by educational grants from Lilly USA, LLC, and Novo Nordisk Inc..
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6+ for Mac OSX 10.7 and above For video playback, install the latest version of Flash or Quicktime. | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |
© 2007-2024 HealthCourse, Inc. All rights reserved.
